dsm-firmenich collaborates with Chinese dairy integrator for Bovaer

dsm-firmenich and China Modern Dairy Holdings have signed a MoU to enhance the sustainability of Chinese dairy farming through the usage of Bovaer®. dsm-firmenich explained it is on track to submit its Chinese registration dossier for Bovaer® later this year and hopes to gain approval in the coming years.

dsm-firmenich collaborates with Chinese dairy integrator for Bovaer Innovators in health, nutrition and beauty, dsm-firmenich and China Modern Dairy Holdings, Ltd., a dairy farming operator and raw milk producer in China, have signed a Memorandum of Understanding (MoU) to enhance the sustainability of Chinese dairy farming through the implementation of Bovaer®. This is the first such agreement in China, according to the announcement.

Bovaer® is one of the most extensively studied and scientifically proven solutions to the challenge of lowering livestock’s methane emissions. In the dairy sector, methane is the most common and powerful greenhouse gas and is mainly generated in the digestive tracts of cows, released when the animals burp. Through the implementation of Bovaer®, methane emissions can be reduced by approximately 30% for dairy.

In November 2023, China launched the “Methane Emission Control Action Plan,” aimed at significantly reducing methane emissions across sectors, including agriculture, in the country. As one of the leading dairy producers in China, China Modern Dairy Holdings is supporting the implementation of this action plan across its operations, by supplying milk with a lower environmental footprint to customers like China Mengniu Dairy, a top 10 global dairy company.

“We are excited to commence preparations to enter the Chinese dairy market. We are on track to submit our Chinese registration dossier for Bovaer® later this year and hope to gain approval in the coming years. The collaboration with Modern Dairy will help us to tailor our offering and go-to-market model for the Chinese market, and we are happy to work with the industry leaders on this topic. Preparation work will start now, while we await local market authorization for commercialization,” said Mark van Nieuwland, Senior Vice President Bovaer® at dsm-firmenich.

Bovaer® is already commercially available in 65 countries including EU member states, the UK, USA, Canada, Mexico, Australia, most of Latin America, and select other markets.